Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023
M Pouyiourou, LE Reitnauer, A Ballhausen… - Oncology Research …, 2024 - karger.com
Standard of care in unfavorable cancer of unknown primary (CUP) typically comprises
platinum-based doublet chemotherapy as first-line treatment, which leads to a median …
platinum-based doublet chemotherapy as first-line treatment, which leads to a median …